Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shannon Tompkins"'
Autor:
Jared J. Herr, Farooq H. Sheikh, Parin J. Patel, Anuradha Lala, Christopher V. Chien, Stephanie Hsiao, Ajay Srivastava, Dawn Pedrotty, Jennifer Nowaczyk, Shannon Tompkins, Sara Ahmed, Fei Xiang, Stephen Forest, Michael Z. Tong, Forum Kamdar, Benjamin D'Souza, Ashwin Ravichandran
Publikováno v:
The American Journal of Cardiology. 185:46-52
Advanced heart failure (HF) therapies improve survival in patients with stage D HF. We sought to evaluate differences by race/ethnicity and sex in advanced HF therapy referrals and decision-making across a multicenter survey. We performed a retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2b5e5d31dbae617a089c434411bb30
https://doi.org/10.1016/j.amjcard.2022.09.015
https://doi.org/10.1016/j.amjcard.2022.09.015
Autor:
Stephanie Hsiao, Ideal-Hf investigators, Sara Ahmed, S. Forest, Christopher V. Chien, Ashwin Ravichandran, Anuradha Lala, Benjamin D’Souza, Shannon Tompkins, Ajay Srivastava, Farooq H. Sheikh, Michael Z Tong, Dawn M. Pedrotty, Fei Xiang, Jennifer Nowaczyk, Jared J Herr
Publikováno v:
Journal of Cardiac Failure. 27:1251-1259
Background Therapies for advanced heart failure (AHF) improve the likelihood of survival in a growing population of patients with stage D heart failure (HF). Successful implementation of these therapies is dependent upon timely and appropriate referr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbfe250df3fc4a7e4cb207f3e8345f72
https://doi.org/10.1016/j.cardfail.2021.05.024
https://doi.org/10.1016/j.cardfail.2021.05.024
Autor:
Sunit-Preet Chaudhry, Shannon Tompkins, Mary Norine Walsh, James P. Adlam, K.L. Morris, Caitlin Hoefer, M. Padanilam, Erica Seasor, Giorgio Zanotti, A. Patel, R. Garcia-Cortes, Christopher T. Salerno, A. Ravichandran, Markian Bochan
Publikováno v:
Clinical transplantationREFERENCES. 34(1)
Introduction Patients with end-stage heart failure eligible for orthotopic heart transplantation (OHT) exceed the number of available donor organs. With highly effective hepatitis C virus (HCV) antiviral therapy now available, HCV+ organs are increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0e3a961e6120d6e9dcea8bfbbe4170
https://pubmed.ncbi.nlm.nih.gov/31830339
https://pubmed.ncbi.nlm.nih.gov/31830339
Autor:
Christopher T. Salerno, M. Padanilam, A. Ravichandran, Markian Bochan, A. Patel, R. Garcia-Cortes, Sunit-Preet Chaudhry, Shannon Tompkins, J.P. Adlam, K.L. Morris
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S265
Purpose Patients with end-stage heart failure eligible for orthotopic heart transplantation (OHT) exceeds the number of available donor organs. With the introduction of curative medications for hepatitis C (HCV), these hearts are now being utilized i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0556af4c052e6cb35cfc68c8993bbe7
https://doi.org/10.1016/j.healun.2019.01.660
https://doi.org/10.1016/j.healun.2019.01.660